Related Experiment Video

Updated: Jan 31, 2026

Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension
10:03

Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension

Published on: June 27, 2025

782

Quantitative ultrasonographic evaluation of the carotid arteries in hypertension

M Mercuri1, K Devi

  • 1Division of Vascular Ultrasound Research, Bowman Gray School of Medicine of Wake Forest University, Winston-Salem, North Carolina, USA.

Journal of Cardiovascular Risk
|February 1, 1995
PubMed

Insights

Hypertension management aims to prevent organ damage. Non-invasive B-mode ultrasound of carotid arteries shows promise for detecting early arterial wall changes and monitoring antihypertensive treatments.

Area of Science:

  • Cardiovascular Medicine
  • Medical Imaging
  • Pharmacology

Background:

  • Hypertension is a key factor in atherogenesis, contributing to arterial wall damage.
  • Current hypertension treatments aim to prevent end-organ injuries.
  • Effective monitoring of arterial health is crucial for managing hypertension.

Purpose of the Study:

  • To highlight the importance of non-invasive methods for detecting early arterial wall abnormalities in hypertensive patients.
  • To evaluate the potential of B-mode ultrasound of carotid arteries in assessing antihypertensive treatments.
  • To identify effective strategies for monitoring long-term effects of therapies on hypertension-related vascular injuries.

Main Methods:

  • Review of current treatment goals for hypertension.
  • Assessment of hypertension's role in atherogenesis.
  • Evaluation of B-mode ultrasound of carotid arteries as a non-invasive screening tool.

Main Results:

  • Hypertension significantly contributes to the development of atherosclerosis.
  • Many antihypertensive medications possess properties that protect the arterial wall.
  • B-mode ultrasound of carotid arteries demonstrates potential for assessing treatment efficacy in preventing vascular injury.

Conclusions:

  • Non-invasive screening methods are essential for early detection of arterial abnormalities in hypertension.
  • B-mode ultrasound of carotid arteries is a promising tool for monitoring the vascular effects of antihypertensive therapies.
  • Further implementation of such methods can improve the management of hypertension and prevent related complications.

More Related Videos

Measuring the Carotid to Femoral Pulse Wave Velocity Cf-PWV to Evaluate Arterial Stiffness05:51

Measuring the Carotid to Femoral Pulse Wave Velocity Cf-PWV to Evaluate Arterial Stiffness

Published on: May 3, 2018

18.5K
Adult Mouse Venous Hypertension Model: Common Carotid Artery to External Jugular Vein Anastomosis.08:27

Adult Mouse Venous Hypertension Model: Common Carotid Artery to External Jugular Vein Anastomosis.

Published on: January 27, 2015

14.7K

Related Concept Videos

Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
862
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors01:28

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
600
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
464
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
507
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure01:16

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
616
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers01:26

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
529